[Pharmacoeconomics of dyspesia and peptic ulcer disease].

The economic impact of medical procedures in the treatment of some diseases is often conducted in USA and some EU countries. Recommendations of experts are different of diagnosis and treatment non ulcer disease (NUD) and peptic ulcer disease (PUD) with or without Helicobacter pylori (HP) infections. This study was to establish various methods of pharmakoekonomics analysis by NUD and PUD.